APA (7th ed.) Citation

Perrier, A., Boelle, P., Chrétien, Y., Gligorov, J., Lotz, J., Brault, D., . . . Boissan, M. (2020). An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Perrier, Alexandre, Pierre-Yves Boelle, Yves Chrétien, Joseph Gligorov, Jean-Pierre Lotz, Didier Brault, Eva Comperat, Guillaume Lefèvre, and Mathieu Boissan. An Updated Evaluation of Serum SHER2, CA15.3, and CEA Levels as Biomarkers for the Response of Patients with Metastatic Breast Cancer to Trastuzumab-based Therapies. Public Library of Science (PLoS), 2020.

MLA (9th ed.) Citation

Perrier, Alexandre, et al. An Updated Evaluation of Serum SHER2, CA15.3, and CEA Levels as Biomarkers for the Response of Patients with Metastatic Breast Cancer to Trastuzumab-based Therapies. Public Library of Science (PLoS), 2020.